How a thieving transcription factor dominates the genome

June 20, 2018 by Lori Dajose, California Institute of Technology
How a thieving transcription factor dominates the genome
DNA-binding protein Runx1 is attracted away from a gene used in T cell development (left) to a site on gene used in progenitor cells or other non-T cells (right), through its interaction with DNA-binding protein PU.1. Runx1: dark blue structure; T-cell gene, yellow and red DNA structure; PU.1 (rainbow structure); non-T cell gene, rainbow DNA structure. Credit: Rothenberg laboratory

One powerful DNA-binding protein, the transcription factor PU.1, steals away other transcription factors and recruits them for its own purposes, effectively dominating gene regulation in developing immune cells, according to a new Caltech-led study. The research was conducted in the laboratory of Ellen Rothenberg, Albert Billings Ruddock Professor of Biology. A paper describing the work appears in the June 19 issue of the journal Immunity.

At some point in a stem cell's life, it must make an irreversible transition to develop into a particular cell type. When this happens, its nucleus begins to bustle with activity: Proteins called transcription factors latch onto the cell's DNA at specific locations (called binding sites) to tune up and down the expression of various . This act of is the key to the diversity of cells we see in the human body—neurons, muscle cells, . However, how transcription factors determine whether they will turn genes on or off is still poorly understood.

Now, a particular transcription factor called PU.1 has been found to steal transcription factors away from their other jobs, not only forcing them to work together with PU.1 but also effectively turning off the genes that those factors were previously working upon.

"Our finding helps us understand how stem cells make decisions about differentiation," says Hiroyuki Hosakawa, senior postdoctoral scholar and the study's co-first author. "Though we specifically studied T cells, we expect that the behavior of these transcription factors is broadly similar to any kind of cell, like muscle or motor neurons. PU.1 seems to be a kind of master transcription factor influencing gene expression."

Genes are like blueprints, encoding for the proteins that build a cell and give it functionality. The first step in the process of decoding a gene is called transcription, where a given gene is read and copied into an RNA form for use in protein synthesis. If a cell needs a lot of a particular protein, its corresponding gene will be upregulated. If a cell no longer needs a protein, that corresponding gene will be downregulated or turned off.

Transcription factors, as their name suggests, regulate transcription by latching onto binding sites on DNA. There are hundreds of different kinds of transcription factors, each factor able to contribute to the control of multiple genes, and each type of factor recognizing a different DNA sequence, called a binding site. These sites are locations where factors can bind with other factors to work together in combinations and modify gene expression. It has been theorized that transcription factors only work on the genes located next to a factor's binding site. However, sometimes the genes that a factor can physically bind to are not the same genes that actually change their expression in response to that factor. This can happen, according to the new research, because of the way transcription factors compete with one another.

One particular transcription factor, PU.1, is only present in early stages of the development of into T cells. It can have a powerful influence: The whole pattern of gene expression in the cells changes when PU.1 disappears from the cells, which is a key milestone in T cell development. Thus, PU.1 is a versatile regulator, able to either crank up or suppress it. Strangely though, at the actual sites where it binds, PU.1 only seems to turn genes on; how it keeps other genes off has been a mystery. Rothenberg and her team aimed to determine how this happens.

The researchers discovered that PU.1 steals other transcription factors. When PU.1 is not present, other transcription factors go about their business, binding to their respective sites on the genome. When PU.1 enters the scene, several other types of transcription factors are drawn to it, neglecting their functions on other genes. As a result, those genes turn off while the genes PU.1 regulates are boosted. Thus, during the early developmental stages when it is present, PU.1 is able to dial down expression of genes that it does not even physically bind to.

"We found that transcription factors can actually control gene expression without directly binding to genes," says co-first author and former postdoctoral scholar Jonas Ungerbäck, now of Lund University in Sweden.

"It explains a lot of mysteries about the fine tuning of biological developmental states," says Rothenberg. "Biological systems are very sensitive, so as soon as there is competition—like between for binding—you can have ripple effects. For PU.1 to actually affect the activity of another factor that's being removed from its normal function, it shows that this factor is very powerful in an unexpected way."

The paper is titled "Transcription factor PU.1 represses and activates in early T by redirecting partner factor binding."

More information: Hiroyuki Hosokawa et al. Transcription Factor PU.1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding, Immunity (2018). DOI: 10.1016/j.immuni.2018.04.024

Related Stories

Recommended for you

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...

Biologists discover process that neutralizes tumors

July 10, 2018
Researchers from the University of California San Diego have identified an unexpected mechanism that could help determine whether a cancer patient will respond to immunotherapy.

Mitochondrial DNA in exosomes is the alarm that initiates the antiviral response

July 10, 2018
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have provided valuable information about the defense mechanisms of the immune system during the early stages of the response to pathogens ...

Antibody identifier could speed development of therapies for cancer, other diseases

July 10, 2018
A research team led by a UCLA bioengineer has developed a model to predict the extent to which new laboratory-designed antibodies will be able to combat specific human diseases. This is the first time that a comprehensive ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.